• Generic Prescribing of Category 3 Antiepileptics• Prescribing of sodium chloride 5% eye ointment• Hold the date: GPNI Webinar – Supporting GP Practices with Opioid Reduction• NICE Guidance (Recently Published)• Managed Entry Decisions• Deprescribing social media campaigns• Deprescribe: Proton pump inhibitors in acid reflux and heartburn in adults
NI Formulary: Management of Glaucoma and Dry Eye• Shortages of Glaucoma Eye Drops• NICE Guidance (Recently Published)• Dysphagia Newsletter• New Training Video: Controlled Drugs in Primary Care• Deprescribing Social Media Campaign• Deprescribe: Antimicrobials in Acne• Deprescribe: Mucolytics
New CEC: Venlafaxine modified release tablets; Deprescribing and social media campaigns; Deprescribe: Opioids for chronic pain; Deprescribe: Bath and shower products; NICE Guidance (Recently Published); Managed Entry Decisions
Melatonin Paediatric Product Selection Guide; Medicines Supply Issues: Where to go to get the most up-to-date information?; Deprescribe: medicines for overactive bladder; NICE Guidance (Recently Published); Managed Entry Decisions
A Focus on Deprescribing; Getting your child to take a tablet; Deprescribing: vitamins, Generic savings opportunity – Toviaz® to Fesoterodine; Guidance (Recently Published); Managed Entry Decisions
Trusts moving to using licensed Xaqua® (metolazone) 5mg tablets; Avoid Selecting a DPI / Breath-Actuated Inhaler when A Spacer Device is Required; Changes to Red Amber List Medicines; Did you see? — Changes to NI Formulary for Chronic Pain; NICE Guidance (Recently Published);Managed entry Decisions
